QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)

Medtronic or Intuitive Surgical: Which is the Better Buy After Earnings?

Wednesday, November 24, 2021 | Chris Markoch
Medtronic or Intuitive Surgical: Which is the Better Buy After Earnings?

The future can’t arrive soon enough for these two medical device giants

I’ve been bullish on both Medtronic (NYSE:MDT) and Intuitive Surgical (NASDAQ:ISRG) at different points this year. However both stocks are under selling pressure even after each company delivered solid, if not spectacular earnings reports.

Medtronic just reported earnings on November 23. The medical device company beat on earnings but missed on revenue. This was, as the company described it, based on fears of hospital schedules and staffing continuing to be disrupted by the global pandemic.

I was briefly correct on a bullish call I made on MDT stock after its earnings report in August. However, the stock is down 16% from its 52-week high and is now in the red for the year.

In the case of Intuitive Surgical, the stock jumped nearly 10% immediately after it beat on both the top and bottom lines. However, since then ISRG stock has given up almost all of those gains.  Still, the stock is up 23% for the year which is roughly the same as the S&P 500.

Intuitive Surgical: A Pure Play on Robotic Surgery

The bullish case for Intuitive Surgical centers around the company’s DaVinci System, the first FDA-approved robotic-assisted, minimally invasive surgical system. The company says the DaVinci system has performed over 8.5 million procedures. And it has sold the system in 67 countries including in all of the 50 states.

The company’s other offering is Ion – a robotic-assisted endoscopy platform that can find small, hard-to-reach lung nodules that can help detect lung cancer.

Intuitive Surgical has over 4,000 patents which is protecting its intellectual property. And, at a price tag between $500,000 and $2.5 million, once a hospital or medical center installs the DaVinci system, it becomes cost prohibitive to replace it. This is reflected in the company’s net margin which is slightly over 30% as of this writing.

Medtronic: A Leader in Medical Devices

Medtronic is a leader in the sale of medical devices and technology. The company sells to hospitals, physicians, clinicians and directly to patients. Although the company had a difficult year in 2020 as many hospitals were shut down at the beginning of the pandemic, the company had a banner year in ventilator sales. And as those sales have trailed off this year, Medtronic has seen its other categories come back strongly. And the company has recently thrown in its hat in the robotic-assisted surgery sector with the launch of its Hugo system.

The bad news is that, for all of its promise, the field of robotic surgery is still a slow growing sector and will continue to add competitors. The good news is that, as long-term stocks, I believe the sector is large enough for both companies.

Which is the Better Buy?

The issue for me is about growth potential. And while both companies have long-term potential, I like Medtronic simply because it has more ways to generate revenue.

In terms of valuation, both stocks are a bit expensive with price-to-earnings (P/E) ratios above their respective sector averages. And this is after Intuitive Surgical’s 3-for-1 stock split earlier this year. However, with a P/E ratio of 39.64 Medtronic is trading at a lower price-to-earnings ratio relative to its sector average of 30.16 than Intuitive Surgical which has a P/E ratio of 72.50 compared to its sector average of 25.64. This is one reason I give the nod to Medtronic.

Another reason is that the company has more ways to generate revenue in what may be a tough environment. And when considering these stocks, it’s impossible to ignore Medtronic’s status as a Dividend Aristocrat. The company has increased its dividend in each of the last 44 years.

Should you invest $1,000 in Medtronic right now?

Before you consider Medtronic, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.

While Medtronic currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Medtronic (MDT)3.5$105.47-1.2%2.39%30.39Buy$144.21
Intuitive Surgical (ISRG)1.7$319.93-1.4%N/A69.05Hold$335.40
Compare These Stocks  Add These Stocks to My Watchlist 

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.